Home
>
National Drug Code (NDC)
>
Anaprox
Anaprox - 0004-6202-01 - (naproxen sodium)
Drug Information of Anaprox
| Product NDC: | 0004-6202 |
| Proprietary Name: | Anaprox |
| Non Proprietary Name: | naproxen sodium |
| Active Ingredient(s): | 275 mg/1 & nbsp; naproxen sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Anaprox
| Product NDC: | 0004-6202 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018164 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19800904 |
Package Information of Anaprox
| Package NDC: | 0004-6202-01 |
| Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0004-6202-01) |
NDC Information of Anaprox
| NDC Code | 0004-6202-01 |
| Proprietary Name | Anaprox |
| Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0004-6202-01) |
| Product NDC | 0004-6202 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | naproxen sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19800904 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | NAPROXEN SODIUM |
| Strength Number | 275 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
